Kliničke studije za ХОБП u državi Њу Џерзи
8 studija za ХОБП traži učesnike na lokacijama u državi Њу Џерзи.
Gradovi u državi Њу Џерзи
Zvanični tekst studije (na engleskom)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Bioluminux Clinical Research - Hamilton, New Jersey- Site Number : 8400037, Hamilton
- Rutgers Institute For Infectious & Inflammatory Diseases (I3d)- Site Number : 8400093, Newark
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Sanmora Bespoke Clinical Research Solutions- Site Number : 8400144, East Orange
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 19. 10. 2026. · NCT07190209This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
- Inspira Medical Center Mullica Hill, Mullica Hill
Тражи се учесникФаза 4
Узраст 40 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07587658Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Moorestown
- GSK Investigational Site, Sewell
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 5. 10. 2026. · NCT06961214A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Mullica Hill
- Research Site, Toms River
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 2. 10. 2026. · NCT06283966A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Millville
- Research Site, Sewell
- Research Site, Toms River
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 3. 9. 2026. · NCT06883305COPD Exacerbation Follow Up
- Cooper University Health Care, Cherry Hill
Тражи се учесникОпсервациона студија
Узраст 40 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT07118306Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Inspira Medical Center, Mullica Hill
Тражи се учесникОпсервациона студија
Узраст 50 и старији · Оба пола · Ажурирано 5. 8. 2025. · NCT06122077Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.